Alzheimer’s Clinical Trial Results, Sadly Running True to Form

There have been some interesting failures recently in Alzheimer’s trials. As long-time readers will know, I consider basically all Alzheimer’s drug trials to have failed to one degree or another, and particularly when it comes to clearing the “will improve patient’s lives in the real world without putting them at too much risk” hurdle. But […]

Novo Nordisk GLP-1 fails to slow Alzheimer’s in trials

Novo Nordisk’s GLP-1 drug semaglutide did not demonstrate a statistically significant effect in slowing progression of Alzheimer’s disease in two late-stage clinical trials. According to a Nov. 24 news release from the company, two double-blinded, placebo-controlled phase 3 trials enrolled 3,808 adults ages 55-85 with mild cognitive impairment or mild dementia. Over a two-year period, […]

Retail Investors on Reddit Like Costco Wholesale (COST), Here’s Why

We recently published Top 10 Non-AI Stocks Redditors are Buying Ahead of Potential Bubble Burst. Costco Wholesale Corp (NASDAQ:COST) is one of the top non-AI stocks redditors are buying. Redditors believe Costco Wholesale Corp (NASDAQ:COST) remains one of the best non-AI stocks for long-term investors. Evercore ISI analyst Greg Melich said in a note last […]

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

NATICK, Mass.–(BUSINESS WIRE)—- $ALUR–Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced initial results on the combination of the Allurion Program with low-dose tirzepatide therapy to optimize muscle mass and GLP-1 adherence. 76 patients treated with the Allurion Smart Capsule were started on low-dose tirzepatide after […]